Trademark: 90838034
Word
MAXINE
Status Date
Thursday, June 6, 2024
Filing Date
Tuesday, July 20, 2021
Published for Opposition
Tuesday, November 8, 2022
5 Vaccine adjuvants; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate the delivery of a wide range of pharmaceuticals
1 Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use
44 Medical services; medical information; providing a website featuring medical information
42 Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
Jul 23, 2021
New Application Entered
Sep 21, 2021
New Application Office Supplied Data Entered
Jan 31, 2022
Assigned To Examiner
Feb 4, 2022
Non-Final Action Written
Feb 4, 2022
Non-Final Action E-Mailed
Feb 4, 2022
Notification Of Non-Final Action E-Mailed
Aug 3, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 3, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 3, 2022
Teas Change Of Correspondence Received
Aug 4, 2022
Teas Response To Office Action Received
Aug 4, 2022
Correspondence Received In Law Office
Aug 4, 2022
Teas/Email Correspondence Entered
Aug 31, 2022
Report Unresponsive Amendment - Completed
Aug 31, 2022
Notice Of Unresponsive Amendment - E-Mailed
Aug 31, 2022
Notification Of Notice Of Unresponsive Amendment - E-Mailed
Aug 31, 2022
Non-Final Action E-Mailed
Aug 31, 2022
Notification Of Non-Final Action E-Mailed
Aug 31, 2022
Non-Final Action Written
Sep 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 8, 2022
Teas Change Of Correspondence Received
Sep 20, 2022
Teas Response To Office Action Received
Sep 20, 2022
Correspondence Received In Law Office
Sep 20, 2022
Teas/Email Correspondence Entered
Sep 29, 2022
Examiner's Amendment Entered
Sep 29, 2022
Examiners Amendment -Written
Sep 29, 2022
Examiners Amendment E-Mailed
Sep 29, 2022
Notification Of Examiners Amendment E-Mailed
Oct 3, 2022
Approved For Pub - Principal Register
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Nov 8, 2022
Published For Opposition
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 12, 2023
Sou Teas Extension Received
Apr 12, 2023
Sou Extension 1 Filed
Apr 12, 2023
Sou Extension 1 Granted
Apr 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2023
Sou Teas Extension Received
Dec 19, 2023
Sou Extension 2 Filed
Dec 19, 2023
Sou Extension 2 Granted
Dec 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 6, 2024
Sou Teas Extension Received
Jun 6, 2024
Sou Extension 3 Granted
Jun 6, 2024
Sou Extension 3 Filed
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
